(SUMMARY OF JOHN’S NOVEMBER 1, 2023 WEBINAR) November 3, 2023 Hello everyone, Webinar Title: The Seasonals are Kicking In Markets are starting to pick up. Performance: 2023 year to date: +66.17% Average Annualized Return: +47.82% Since inception for 15 years: 663.36% Trailing one-year return: 74.44% Positions: Risk On NVDA 11/370-380
Global Market Comments November 3, 2023 Fiat Lux Featured Trade: (NOVEMBER 1 BIWEEKLY STRATEGY WEBINAR Q&A), (BRK/B), (TSLA), (LLY), (SNOW), (BIB), (BIB), (CCJ), (FXA), (FXB), (FXE), (EEM), (GLD), (SLV) (UNG), (LNG)
Below please find subscribers’ Q&A for the November 1 Mad Hedge Fund Trader Global Strategy Webinar, broadcast from Boca Raton. Q: Earlier you said that the bull market should start from here—are you sticking to that argument? A: Yes, there are all kinds of momentum and cash flow indicators that are flashing “buy right now.”
Mad Hedge Biotech and Healthcare Letter November 2, 2023 Fiat Lux Featured Trade: (SLICING THROUGH DOUBT) (CRSP), (VRTX), (BLUE), (BEAM), (AMGN), (REGN)
In the intricate world of medical breakthroughs, September 14, 1990, stands out like a sore thumb—or perhaps, a healing one. On this day, the baseball world was left agog as Ken Griffey Jr. and Sr. knocked out back-to-back home runs, a feat as rare as hen’s teeth. Meanwhile, in a quieter corner of the planet,
Global Market Comments November 2, 2023 Fiat Lux Featured Trade: (THE SECOND AMERICAN INDUSTRIAL REVOLUTION), (INDU), (SPY), (QQQ), (GLD), (DBA), (TSLA), (GOOGL), (XLK), (IBB), (XLE) (TESTIMONIAL)
(THIS AI STOCK IS GAINING ATTENTION) November 1, 2023 Hello everyone, Welcome to November. Wall Street is upbeat about an AI stock called Arista. On Monday, the company earnings exceeded Wall Street expectations on both the top and bottom lines. Earnings: $1.83/share Revenue: $1.51 Analysts forecast: Earnings: $1.58/share Revenue: $1.48 billion Arista also
Mad Hedge Biotech and Healthcare Letter October 31, 2023 Fiat Lux Featured Trade: (A SEA OF POSSIBILITIES) (PFE), (MRNA), (NVAX)
In the cutthroat world of pharmaceuticals, Pfizer (PFE) seems to be having a bit of a moment. And not the kind you'd want to experience yourself. With shares flirting dangerously close to their 52-week low, investors are left scratching their heads. Is this a rare stock market sale, or is Pfizer showing us warning signs?
Global Market Comments October 31, 2023 Fiat Lux ANOTHER SPECIAL SOLAR ISSUE Featured Trade: (HOW TO BUY A SOLAR SYSTEM), (SCTY), (SPWR), (TSLA), (USO)